Cervical Health
We offer a comprehensive cervical cancer screening portfolio, from sample collection to diagnosis. Our leading technologies provide effective, robust and proven end-to-end solutions that meet the needs of all commonly used national cervical cancer screening programs.
HPV Solution
HPV testing is advancing precision detection and the identification of women most at risk from cervical disease. The Aptima® HPV assay targets mRNA within the 14 high-risk types of HPV, identifying active and clinically relevant infection. This more targeted approach is beneficial for patients and maximises resources.1
Genius™ Digital Diagnostics System
The Genius Digital Diagnostics System is the first cytology solution to combine the power of a new, deep learning-based AI algorithm with advanced volumetric imaging technology to identify pre-cancerous lesions and cervical cancer cells.2
Cytology Solution
The ThinPrep® Pap Test is a worldwide standard widely used for cervical sample collection. Just one patient sample is required for both cytology and molecular testing, and the follow-up reflex test can be directly performed from the same primary sample. It's a comprehensive cytology solution, from sample collection to diagnosis.
A Total Screening Solution
We pride ourselves on being champions of women’s health and global leaders in screening, dedicated to advancing the accuracy and early detection of cervical cancer. We bring clinical confidence and workflow efficiency to labs and clinicians through our market-leading ThinPrep® Pap test and Aptima HPV assay. We are also pushing the boundaries of cytology with the new GeniusTM Digital Diagnostics System.
Advancing Precision Detection Together
We provide the information that healthcare providers need to guide earlier detection of cervical cancer and consequently make better treatment decisions for their patients.
For more than 30 years, our expert team of cervical health scientists, engineers, application specialists and customer service managers have been chosen and trusted to support the delivery of regional and national cervical screening programmes throughout the world.
1. Aptima HPV Assay [package insert] AW-22202 Rev 001. San Diego, CA: Hologic, Inc.; 2023
2. Genius Digital Diagnostics_CE Mark Press Release_FINAL_11.15.20
2797
Hologic BV, DA Vincilaan 5, 1930 Zaventem, Belgium
Notified Body number wherever applicable